IL69751A - Diazabicyclo-(3.3.1)-nonanes,intermediates therefor,their preparation and pharmaceutical compositions containing them - Google Patents

Diazabicyclo-(3.3.1)-nonanes,intermediates therefor,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL69751A
IL69751A IL69751A IL6975183A IL69751A IL 69751 A IL69751 A IL 69751A IL 69751 A IL69751 A IL 69751A IL 6975183 A IL6975183 A IL 6975183A IL 69751 A IL69751 A IL 69751A
Authority
IL
Israel
Prior art keywords
nonanes
diazabicyclo
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL69751A
Other languages
English (en)
Other versions
IL69751A0 (en
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of IL69751A0 publication Critical patent/IL69751A0/xx
Publication of IL69751A publication Critical patent/IL69751A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Oxide Ceramics (AREA)
IL69751A 1982-09-18 1983-09-16 Diazabicyclo-(3.3.1)-nonanes,intermediates therefor,their preparation and pharmaceutical compositions containing them IL69751A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823234697 DE3234697A1 (de) 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane

Publications (2)

Publication Number Publication Date
IL69751A0 IL69751A0 (en) 1983-12-30
IL69751A true IL69751A (en) 1986-10-31

Family

ID=6173602

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69751A IL69751A (en) 1982-09-18 1983-09-16 Diazabicyclo-(3.3.1)-nonanes,intermediates therefor,their preparation and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (2) US4550112A (xx)
EP (2) EP0103833B1 (xx)
JP (2) JPS5970686A (xx)
AT (2) ATE45579T1 (xx)
AU (1) AU564910B2 (xx)
CA (1) CA1254209A (xx)
CS (1) CS389891A3 (xx)
DD (1) DD213923A5 (xx)
DE (3) DE3234697A1 (xx)
DK (1) DK165833C (xx)
ES (1) ES8405398A1 (xx)
FI (1) FI76338C (xx)
GE (1) GEP19960316B (xx)
GR (1) GR78722B (xx)
HU (1) HU191096B (xx)
IE (1) IE57580B1 (xx)
IL (1) IL69751A (xx)
MX (1) MX9202996A (xx)
NO (1) NO160516C (xx)
NZ (1) NZ205627A (xx)
PH (1) PH20768A (xx)
PT (1) PT77344B (xx)
SU (1) SU1272989A3 (xx)
UA (1) UA817A1 (xx)
ZA (1) ZA836185B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3529872A1 (de) * 1985-08-21 1987-02-26 Kali Chemie Pharma Gmbh Neue tetraoxoverbindungen
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
DE3722134A1 (de) * 1987-07-04 1989-01-19 Kali Chemie Pharma Gmbh 3-sulfonyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4421324A1 (de) 1994-06-17 1995-12-21 Kali Chemie Pharma Gmbh Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
US20040229900A1 (en) * 1999-06-16 2004-11-18 Astrazeneca Ab Bispidine compounds useful in the treatment of cardiac arrythmias
SE9902270D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
US20050004113A1 (en) * 1999-06-16 2005-01-06 Astrazeneca Ab New bispidine compounds useful in the treatment of cardiac arrhythmias
SE9904765D0 (sv) 1999-12-23 1999-12-23 Astra Ab Pharmaceutically-useful compounds
SE0002603D0 (sv) * 2000-07-07 2000-07-07 Astrazeneca Ab New compounds
US6808924B1 (en) 2000-07-11 2004-10-26 Claudia Lanari Mouse mammary tumor lines expressing estrogen and progesterone receptors
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
SE0100326D0 (sv) * 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
DE10131217A1 (de) 2001-06-28 2003-01-09 Solvay Pharm Gmbh 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
CN1822833A (zh) * 2003-07-21 2006-08-23 索尔瓦药物有限公司 3,7－二氮杂双环[3,3,1]壬烷化合物在治疗和/或预防男性患者心律失常中的用途
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
WO2005030207A1 (en) * 2003-09-26 2005-04-07 Solvay Pharmaceuticals Gmbh Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome
SE0302775D0 (sv) * 2003-10-20 2003-10-20 Astrazeneca Ab Chemical compound and assay
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
AU2006258293B2 (en) * 2005-06-13 2010-06-17 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
US10399926B1 (en) 2018-08-01 2019-09-03 Divi's Laboratories Ltd. Process for the preparation of gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
LU76173A1 (xx) * 1976-11-11 1978-07-10
DE2658558A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2726571A1 (de) * 1977-06-13 1978-12-21 Basf Ag Neue bispidinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Also Published As

Publication number Publication date
AU1920683A (en) 1984-03-22
US4550112A (en) 1985-10-29
FI833339A (fi) 1984-03-19
ZA836185B (en) 1984-04-25
DE3234697A1 (de) 1984-03-22
ATE45579T1 (de) 1989-09-15
ES525653A0 (es) 1984-06-01
DE3382466D1 (de) 1992-01-09
IE832186L (en) 1984-03-18
EP0103833B1 (de) 1989-08-16
GEP19960316B (en) 1996-06-24
PT77344A (en) 1983-10-01
FI833339A0 (fi) 1983-09-19
EP0250903B1 (de) 1991-11-27
US4742172A (en) 1988-05-03
EP0250903A2 (de) 1988-01-07
GR78722B (xx) 1984-10-02
DK422583D0 (da) 1983-09-16
ES8405398A1 (es) 1984-06-01
FI76338C (fi) 1988-10-10
EP0103833A2 (de) 1984-03-28
FI76338B (fi) 1988-06-30
NO160516C (no) 1989-04-26
DK165833B (da) 1993-01-25
PH20768A (en) 1987-04-10
PT77344B (en) 1986-03-11
CA1259998C (xx) 1989-09-26
EP0103833A3 (en) 1984-11-28
ATE69817T1 (de) 1991-12-15
MX9202996A (es) 1992-07-01
JPH05247039A (ja) 1993-09-24
CA1254209A (en) 1989-05-16
SU1272989A3 (ru) 1986-11-23
AU564910B2 (en) 1987-09-03
JPH0670056B2 (ja) 1994-09-07
UA817A1 (uk) 1993-12-15
NO833346L (no) 1984-03-19
NO160516B (no) 1989-01-16
IL69751A0 (en) 1983-12-30
DE3380409D1 (de) 1989-09-21
JPS5970686A (ja) 1984-04-21
DK422583A (da) 1984-03-19
EP0250903A3 (en) 1988-03-09
HU191096B (en) 1987-01-28
DK165833C (da) 1993-06-21
NZ205627A (en) 1985-11-08
DD213923A5 (de) 1984-09-26
IE57580B1 (en) 1993-01-13
CS389891A3 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
IL69751A (en) Diazabicyclo-(3.3.1)-nonanes,intermediates therefor,their preparation and pharmaceutical compositions containing them
IL76454A (en) Diarylacetylene derivatives,their preparation and pharmaceutical compositions containing them
IL76457A (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
JPS5573662A (en) Novel hydroxyethyllazole compound*its manufacture and its use as medicine
JPS5665869A (en) Novel 22hydroxyalkyll3*4*55trihydroxyypiperidine compound* its manufacture and drug
DE3028340C2 (xx)
IL95370A0 (en) Halogenoalkylphenyl-alcohols,ketones and hydrates thereof,their production and pharmaceutical compositions containing them
DE3369983D1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL66028A0 (en) Saturated aminocyclitol derivatives,their preparation and pharmaceutical compositions containing them
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
ES8304571A1 (es) "procedimiento para la preparacion de nuevas 1,4,9,10-tetrahidro-pirazolo (4,3-e)pirido (3,2-b) (1,4)diazepin-10-onas".
DE3269505D1 (en) Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it
ES2027492A6 (es) Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables.
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
GR3015706T3 (en) Benzylselenobenzamides of aminopyridines and picolylamines.
IL99782A0 (en) Ergoline derivatives,their production and pharmaceutical compositions containing them
ES8105713A1 (es) Un procedimiento para la preparacion de los enatiomeros levogiro y dextrogiro de la 1-ciclopropil-metil-4-(3-metoxi-5h- dibenzo (a,d) ciclohepten-5-iliden) piperidina

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
EXP Patent expired